Yale New Haven Hospital, Inc.

Yale New Haven Hospital, Inc., a non-profit healthcare provider headquartered in New Haven, Connecticut, operates as a prime contractor and grant sub-recipient delivering clinical laboratory testing, specialized medical services, and public health data collection to federal agencies without set-aside designation. The hospital is a subsidiary of Yale New Haven Health Services Corporation and has maintained federal contractor status since 2003.

The hospital's federal footprint centers on the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 1, which accounts for 52 awards (45% of total awards) and $17.2 million in combined potential value. The VA relationship anchors on two clinical-service vehicles: a single-award BPA for STAT and non-STAT laboratory testing services carrying a $6.51 million ceiling through January 31, 2035, and a definitive contract for perfusion and autotransfusion services valued at $1.91 million (November 1, 2025 through October 31, 2030). Recent VA awards include a $400,000 BPA call for STAT and non-STAT laboratory testing (February 1, 2026, completion January 31, 2027) and a $147,588 BPA call for STAT and routine testing services (February 1, 2025, completion January 31, 2026), both performed in New Haven. The hospital also holds a $2.72 million Consumer Product Safety Commission purchase order for data collection on consumer product-related injuries running through June 30, 2028, representing the second-largest customer by potential value ($5.6 million across seven awards). Beyond VA and CPSC contracts, the hospital serves the Department of Transportation National Highway Traffic Safety Administration (eight awards), the Federal Emergency Management Agency (thirteen awards, majority sub-awards), and the Department of Justice Office of Justice Programs (four awards).

The top five customer agencies by award count represent 74% of all awards and span clinical services, public health surveillance, and emergency management. Awards obligated ($108.6 million) substantially exceed combined potential value ($24.2 million), reflecting the hospital's multi-year performance history and the amortization of large vehicles across many call orders.

Yale New Haven Hospital's capability portfolio, grounded in NAICS concentration (General Medical and Surgical Hospitals, Medical Laboratories) and PSC codes (Reference Laboratory Testing, Medical-Other, Support-Management Data Collection), reflects its core strengths: routine and stat laboratory testing for veteran patient populations, surgical support through perfusion services, consumer injury surveillance, and specialized clinical instruction. Across SCI-reportable prime service contracts (FY2022–FY2024), the hospital invoiced $746 thousand on federal services work. Government-paid hourly rates on SCI records median around $166.99 per hour, with senior labor pricing reaching $238,686.11 per hour (likely reflecting lump-sum or non-standard billing arrangements on specialized contracts). The hospital does not characteristically engage subcontractors on its federal work; across SCI prime records, sub-hours share averaged zero percent.

On the grant side, Yale New Haven Hospital acts as a sub-recipient under state and university prime grantees, delivering violence intervention programming through the Connecticut Judicial Branch's Violence Intervention Program (awards dated June 24, 2026, June 27, 2025, and June 30, 2022), trauma-informed care services, intensive family preservation services through Connecticut Department of Social Services, community traffic safety programming, and clinical training participation under Emory University's National Ebola Training and Education Center and Johns Hopkins University's COVID Protection After Transplant study. The hospital also performs physician assistant reimbursement work under Connecticut Department of Emergency Services and Public Protection sub-awards dating from 2021 forward.

Three awards (combined potential value $3.1 million) face ultimate completion within the next twenty-four months, creating near-term recompete exposure primarily centered on the VA laboratory testing and perfusion services contracts.